RecruitingNCT05658913

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)


Sponsor

University of Pennsylvania

Enrollment

100 participants

Start Date

Mar 14, 2023

Study Type

OBSERVATIONAL

Summary

To collect Tau PET/CT imaging in older adults diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) in the Mismatch Prospective Cohort Study (MPC-Tau) study to determine relationship to clinical, cognitive, and other biomarker data. Findings from this study will likely provide insight into the phenotypic variability of Alzheimer's Disease and other related pathologies.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study adds a specialized brain scan called a Tau PET scan (using a tracer called AV-1451) to an existing research program, to help scientists learn more about how tau protein — a hallmark of Alzheimer's disease — builds up in the brain over time. **You may be eligible if...** - You are already enrolled in the Mismatch Prospective Cohort (MPC) study at the University of Pennsylvania or Massachusetts General Hospital - You have a reliable person (study partner) who can come with you to the scan - You had a high-quality brain MRI within the past 6 months **You may NOT be eligible if...** - You have a medical or psychiatric condition that would make participation unsafe - You have a large structural abnormality on your brain MRI (like a major stroke or mass) - You cannot tolerate or have contraindications to the PET scan Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAV-1451

This is a cross-sectional study using the radiotracer AV-1451 to determine the relationship of tau pathology to other biomarker data of MPC participants.


Locations(2)

Massachusetts General Hospital

Boston, Massachusetts, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05658913